Advertisement

Topics

India targeting a $40 billion domestic biosimilars market by 2030

07:51 EDT 7 Aug 2017 | thePharmaLetter

The Indian biosimilar drugs industry is poised for exponential growth owing to the increasing acceptance,…

Original Article: India targeting a $40 billion domestic biosimilars market by 2030

NEXT ARTICLE

More From BioPortfolio on "India targeting a $40 billion domestic biosimilars market by 2030"

Quick Search
Advertisement
 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...